AVITA Therapeutics is a regenerative medicine company with a technology platform to address unmet medical needs in burns, chronic wounds and aesthetics indications. Treatment solutions are derived from the regenerative properties of a patient’s own skin. RECELL is the company’s flagship product. In basic terms, RECELL can be used by doctors to ‘respray’ skin cells onto a patient suffering from some type of injury (e.g. a burn). The product takes a small amount of the patient’s skin as a sample and in around 30 minutes a spray can be created and applied.
AVITA Therapeutics is a regenerative medicine company with a technology platform to address unmet medical needs in burns, chronic wounds and aesthetics indications. Treatment solutions are derived from the regenerative properties of a patient’s own skin. RECELL is the company’s flagship product. In basic terms, RECELL can be used by doctors to ‘respray’ skin cells onto a patient suffering from some type of injury (e.g. a burn). The product takes a small amount of the patient’s skin as a sample and in around 30 minutes a spray can be created and applied.
The Avita Therapeutics Inc (ASX: AVH) share price was trading 10.53% lower today following an investor update to do with its BARDA partnership.
The Avita (ASX:AVH) share price is down more than 1% after providing an update for FY20.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.01% at lunch.
The AVITA Medical (ASX:AVH) share price is up more than 7.5% this morning after making an announcement.
The Avita Therapeutics Inc (ASX: AVH) share price was trading 10.53% lower today following an investor update to do with its BARDA partnership.
The Avita (ASX:AVH) share price is down more than 1% after providing an update for FY20.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.01% at lunch.
The AVITA Medical (ASX:AVH) share price is up more than 7.5% this morning after making an announcement.
The information on this website is general financial advice only. That means, the advice does not take into account your objectives, financial situation or needs. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. Please read our Terms & Conditions and Financial Services Guide before using this website.
© Rask Australia 2020